With facilities in Gainesville, Florida; Research Triangle Park, North Carolina; and The Woodlands, Texas, Kincellis combines broad technical expertise with flexible, scalable GMP infrastructure across autologous and allogeneic therapies, including but not limited to CAR-T, Tregs, CAR-NK, MSCs, dendritic cell vaccines, exosomes, iPSCs & synthetic mRNA. Serve as a hands-on technical resource and primary backup for microbiological testing activities, maintaining proficiency in applicable microbiological methods, including sterility, bacterial endotoxin, bioburden, growth promotion, environmental monitoring, compressed gas testing, microbial identification, Gram staining, and other applicable assays.